- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | Janssen acquires rights to novel AMD gene therapy | ||
| Do | Licensing deal set to enhance CRISPR/Cas libraries for target discovery and drug development | ||
| Do | UK rolls out COVID-19 vaccine: Who gets the first doses? | ||
| Do | Merck and Transcenta partner to advance continuous manufacturing for protein biotherapeutics | ||
| Mi | Preparing for the pivot to downstream continuous processing | ||
| Mi | Addressing barriers to the shift to downstream continuous processing | ||
| Mi | Erbi Biosystems' platform is designed to support continuous processing, and startup flags its potential to transform CAR-T and other autologous therapies | ||
| Mi | Pfizer and BioNTech COVID-19 vaccine authorized for use in the UK | ||
| Di | Johnson & Johnson starts rolling review for COVID-19 vaccine in Europe | ||
| Di | Pfizer and Moderna apply for European COVID-19 vaccine authorization | ||
| Di | An experimental gene therapy may be effective for MND patients with a newly discovered genetic mutation | ||
| Di | Researchers make 'exciting first step' to better understanding development and treatment of autism | ||
| Mo | Small but mighty: Finnish company flags its nanoparticle technology as potential gamechanger for biologics sector | ||
| Mo | Are stable producer cells the future of viral vector manufacturing and when will allogeneic cell therapy take hold? | ||
| Mo | Could Pfizer's COVID-19 vaccine get the green light in the UK this week? | ||
| Mo | Moderna submits EUA request for COVID-19 vaccine: "We believe our vaccine will provide a new and powerful tool that may change the course of this pandemic" | ||
| 26.11. | BioNTech & InstaDeep launch AI innovation lab for next-generation vaccines and biopharmaceuticals | ||
| 26.11. | BioInvent inks antibody manufacturing agreement with Cantargia | ||
| 26.11. | Compulsory licensing is not an effective policy tool, warns EU biopharma group as it reacts to European IP action plan | ||
| 25.11. | New EU pharma strategy looks to future-proof healthcare sector, stimulate innovation and boost access to biosimilars and generics | ||
| 24.11. | Transforming cold chain infrastructure: 'Ultra-cold smart container can transport all of the leading vaccine candidates for COVID-19' | ||
| 24.11. | Europe makes deal with Moderna for 160 million doses of COVID-19 vaccine | ||
| 24.11. | GlaxoSmithKline takes RSV maternal vaccine candidate into Phase 3 study | ||
| 24.11. | CureVac inks manufacturing deal with Wacker for its COVID-19 vaccine candidate | ||
| 23.11. | Merck to acquire Oncolmmune, accelerating development of COVID-19 treatment candidate |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
